To access this element change to forms mode OFF
Grant Award View - GA187357
Identification and assessment of new treatment options for the childhood...
GA ID:
GA187357
Agency:
Department of Health and Aged Care
Approval Date:
11-Jun-2021
Publish Date:
30-Aug-2021
Category:
Health and Medical Research
Grant Term:
11-Jun-2021 to 31-Jul-2024
Value (AUD):
$982,101.20
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_Stem_Cell_Therapies_Mission
Grant Activity:
Identification and assessment of new treatment options for the childhood cancer Neuroblastoma
Purpose:
Neuroblastoma is a devastating childhood cancer that is the leading cause of cancer related death in children under the age of five. Current therapies for high-risk patients are highly damaging and often lead to profound life-long side effects. Our work aims to understand the biological origin of this disease and to develop new personalised therapies for high-risk neuroblastoma patients.
GO ID:
GO Title:
MRFF – Stem Cell Therapies Mission – 2020 Stem Cell Therapies Grant Opportunity
Internal Reference ID:
MRF2009101
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of South Australia
Recipient ABN:
37 191 313 308
Grant Recipient Location
Suburb:
Mawson Lake
Town/City:
Mawson Lake
Postcode:
5095
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, SA, QLD
Postcode:
Multiple
Country:
AUSTRALIA